These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. Almer G; Vukosavic S; Romero N; Przedborski S J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851 [TBL] [Abstract][Full Text] [Related]
23. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment. Park JH; Jang HR; Lee IY; Oh HK; Choi EJ; Rhim H; Kang S Hum Mol Genet; 2017 Sep; 26(18):3615-3629. PubMed ID: 28666328 [TBL] [Abstract][Full Text] [Related]
24. A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model. Post J; Kogel V; Schaffrath A; Lohmann P; Shah NJ; Langen KJ; Willbold D; Willuweit A; Kutzsche J Molecules; 2021 Mar; 26(6):. PubMed ID: 33805709 [TBL] [Abstract][Full Text] [Related]
25. Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis. Tada S; Okuno T; Yasui T; Nakatsuji Y; Sugimoto T; Kikutani H; Sakoda S J Neuroinflammation; 2011 Feb; 8():19. PubMed ID: 21345177 [TBL] [Abstract][Full Text] [Related]
26. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487 [TBL] [Abstract][Full Text] [Related]
27. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis. Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020 [TBL] [Abstract][Full Text] [Related]
28. Early decrease of redox factor-1 in spinal motor neurons of presymptomatic transgenic mice with a mutant SOD1 gene. Manabe Y; Warita H; Murakami T; Shiote M; Hayashi T; Nagano I; Shoji M; Abe K Brain Res; 2001 Oct; 915(1):104-7. PubMed ID: 11578626 [TBL] [Abstract][Full Text] [Related]
29. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883 [TBL] [Abstract][Full Text] [Related]
30. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389 [TBL] [Abstract][Full Text] [Related]
31. Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis. Sone J; Niwa J; Kawai K; Ishigaki S; Yamada S; Adachi H; Katsuno M; Tanaka F; Doyu M; Sobue G J Neurosci Res; 2010 Jan; 88(1):123-35. PubMed ID: 19610091 [TBL] [Abstract][Full Text] [Related]
32. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261 [TBL] [Abstract][Full Text] [Related]
33. Muscle atrophy and motor neuron degeneration in human NEDL1 transgenic mice. Zhang L; Haraguchi S; Koda T; Hashimoto K; Nakagawara A J Biomed Biotechnol; 2011; 2011():831092. PubMed ID: 20976258 [TBL] [Abstract][Full Text] [Related]
34. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
35. Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice. Lee J; Ryu H; Kowall NW Biochem Biophys Res Commun; 2009 Sep; 387(1):202-6. PubMed ID: 19580782 [TBL] [Abstract][Full Text] [Related]
37. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Kim J; Kim TY; Cho KS; Kim HN; Koh JY Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729 [TBL] [Abstract][Full Text] [Related]
38. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702 [TBL] [Abstract][Full Text] [Related]
39. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons. Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847 [TBL] [Abstract][Full Text] [Related]
40. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Ayers JI; Fromholt SE; O'Neal VM; Diamond JH; Borchelt DR Acta Neuropathol; 2016 Jan; 131(1):103-14. PubMed ID: 26650262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]